Analyst firms · Needham · COLL

Needham COLL price target and rating history

Collegium Pharmaceutical Inc. (COLL) · Health Care

Needham rates Collegium Pharmaceutical Inc. (COLL) Buy with a $46 price target, as of its latest action on Jan 10, 2025. It has published 7 rating actions on COLL since August 2021, including 1 upgrade and 1 downgrade. Across 4 firms with a COLL price target in the last 12 months, the median target is $49.50.

Current rating
Buy
Price target
$46
Median target, all firms
$49.50
Actions on COLL
7

Needham price target on COLL

$46$36$2620222023202420252026
Needham price target on COLL, each point a stated target, August 2021 to January 2025.

Every Needham rating on COLL

How other firms rate COLL

Each firm's latest rating and stated target in the last 12 months.

FirmRatingPrice targetDate
OppenheimerOutperform$50Sep 23, 2026
Truist SecuritiesBuy$49Sep 9, 2026
Leerink PartnersOutperform$45Sep 9, 2026
BarclaysOverweight$58Dec 9, 2025

Questions about Needham and COLL

What is Needham's price target for COLL?
Needham's latest stated price target for Collegium Pharmaceutical Inc. (COLL) is $46, from its action on Jan 10, 2025.
What is Needham's rating on COLL?
Needham rates COLL Buy, a bullish rating, as of Jan 10, 2025.
When did Needham last change its view on COLL?
On Jan 10, 2025, Needham upgrades to Buy from Hold, price target $46.
How does Needham's COLL target compare with other analysts?
Across 4 firms with a COLL price target in the last 12 months, the median target is $49.50.

More COLL rating histories

All Needham ratingsCOLL news and filingsEvery analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.